Eplerenone for chronic central serous chorioretinopathy

Lancet. 2020 Nov 14;396(10262):1556-1557. doi: 10.1016/S0140-6736(20)32327-8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Central Serous Chorioretinopathy* / diagnosis
  • Central Serous Chorioretinopathy* / drug therapy
  • Double-Blind Method
  • Eplerenone
  • Humans
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Spironolactone / therapeutic use

Substances

  • Mineralocorticoid Receptor Antagonists
  • Spironolactone
  • Eplerenone